Feature Image

HempMeds®, Subsidiary of Medical Marijuana, Inc., Launches New High-Potency CBD Formulation of Its Active Relief Roll-On Topical

Posted on

SAN DIEGO, Feb. 27, 2020 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has launched a new high-cannabidiol (CBD) formulation of its popular Active Relief Roll-On topical product.